Status:

UNKNOWN

Tocilizumab in Coronavirus-19 Positive Patients

Lead Sponsor:

University of Calgary

Conditions:

Covid19

COVID-19

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

This is a cohort study of COVID-19 patients with hyperinflammation. It aims to determine the impact of adjunctive Tocilizumab (TCZ) to standard of care on the reduction of hyperinflammation-related mo...

Detailed Description

The novel coronavirus, SARS-Cov2/COVID-19, emerged in late 2019 in Wuhan, China. Quickly, SARS-CoV2 spread to all corners of the globe. In March 2020, The World Health Organization (WHO) declared SARS...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years
  • All genders
  • Hospitalization for suspected or confirmed SARS-CoV2 infection. COVID-19 diagnosis defined as positive on reverse-transcriptase polymerase chain reaction, with provincial laboratory confirmation.
  • Signs of hyperinflammation (cytokine release syndrome) defined by the presence of any of the following:
  • i. Elevated C-reactive protein (≥70 mg/dl and/or rising since last 24h not due to bacterial infection), ii. Ferritin (\>700 mcg/L and/or rising since last 24h),
  • Anti-interleukin treatment indication as per hyperinflammation team
  • Informed consent for participation in the study

Exclusion

  • Goal of Care C (palliative care)
  • Known hypersensitivity to TCZ or its components
  • Current systemic immunosuppressive therapy; anti-interleukin 1 or anti-interleukin 6 treatment
  • Known active bacterial or fungal infections or other clinical conditions that contraindicate TCZ and cannot be treated or resolved according to the physician's judgment
  • Current or history of bowel perforation or diverticulitis
  • Suspicion of active or latent tuberculosis
  • Pregnant or breastfeeding patient
  • Patients with known prior liver disease

Key Trial Info

Start Date :

July 30 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2021

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04423042

Start Date

July 30 2020

End Date

June 1 2021

Last Update

July 22 2020

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.